Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, Ziqiang Road 139, Shijiazhuang, 050051, Hebei, China.
J Orthop Surg Res. 2022 Sep 5;17(1):405. doi: 10.1186/s13018-022-03304-0.
The objective of present study was to investigate the therapeutic effects of high tibial osteotomy (HTO) combined with platelet-rich plasma (PRP) for severe knee osteoarthritis (KOA).
This was a double-blinded, randomized, placebo-controlled trial. The participants were randomly divided by computerderived random charts into 3 groups: 24 participants in group A (24 knees) received a treatment option of HTO combined with PRP, 25 participants in group B (25 knees) received a treatment program of HTO combined with hyaluronic acid, and 25 participants in group C (25 knees) received a treatment method of HTO combined with normal saline (NS) (physiological control/placebo). The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and visual analog scale (VAS) were measured preoperatively and at the final follow-up. Status of articular cartilage was assessed according to the International Cartilage Repair Society grade and the presence of newly formed cartilaginous tissue by arthroscopy. MRI was completed of knee joint to measure the cartilaginous thickness.
Compared to Group B and C, the final follow-up results of knee function in Group A were significantly different (P < 0.001), such as the total WOMAC score 18.54 (SD 4.17), the VAS score 1.72 (SD 0.53). Cartilage regeneration of femur and tibia in Group A was observed in all patients. The cartilaginous thickness in Group A were significantly different (P < 0.001), such as the anterior patella femoral region 3.52 (SD 0.47), the anterior meniscal region 1.16 (SD 0.24), the posterior meniscal region 1.24 (SD 0.26) and the posterior condyle region 2.25 (SD 0.31).
The addition of combined PRP to HTO may be a more reasonable choice to relieve knee pain and decelerate the progression of the medial KOA.
本研究旨在探讨高位胫骨截骨术(HTO)联合富血小板血浆(PRP)治疗重度膝骨关节炎(KOA)的疗效。
这是一项双盲、随机、安慰剂对照试验。参与者通过计算机生成的随机图表分为 3 组:A 组 24 名患者(24 膝)接受 HTO 联合 PRP 治疗方案,B 组 25 名患者(25 膝)接受 HTO 联合透明质酸治疗方案,C 组 25 名患者(25 膝)接受 HTO 联合生理盐水(NS)(生理对照/安慰剂)治疗方法。术前和最终随访时采用西部安大略省和麦克马斯特大学骨关节炎指数(WOMAC)和视觉模拟评分(VAS)进行评估。根据国际软骨修复协会(ICRS)分级评估关节软骨状况,并通过关节镜检查评估新形成的软骨组织。对膝关节进行 MRI 检查以测量软骨厚度。
与 B 组和 C 组相比,A 组膝关节功能的最终随访结果差异有统计学意义(P<0.001),如总 WOMAC 评分为 18.54(SD 4.17),VAS 评分为 1.72(SD 0.53)。A 组所有患者均观察到股骨和胫骨的软骨再生。A 组的软骨厚度差异有统计学意义(P<0.001),如髌骨前区 3.52(SD 0.47),半月板前区 1.16(SD 0.24),半月板后区 1.24(SD 0.26)和后髁区 2.25(SD 0.31)。
HTO 联合 PRP 可能是缓解膝关节疼痛和减缓内侧 KOA 进展的更合理选择。